Skip to content

Biotechnology company Regeneron buying 23andMe for $256 million

23andMe has faced an uncertain future for some time.

FILE – This March 25, 2025 photo shows a 23andMe saliva collection kit in Oakland, Calif. (AP Photo/Barbara Ortutay, File)
FILE – This March 25, 2025 photo shows a 23andMe saliva collection kit in Oakland, Calif. (AP Photo/Barbara Ortutay, File)
Author
UPDATED:

23andMe has faced an uncertain future for some time.

Subscribe to continue reading this article.

Already subscribed? To log in, click here.

Originally Published:

RevContent Feed

Page was generated in 2.3159301280975